Cargando…

Licensing Natural Killers for Antiviral Immunity

Immunoreceptor tyrosine-based inhibitory motif (ITIM)-bearing receptors (IRs) enable discrimination between self- and non-self molecules on the surface of host target cells. In this regard, they have a vital role in self-tolerance through binding and activating intracellular tyrosine phosphatases wh...

Descripción completa

Detalles Bibliográficos
Autores principales: Cronk, John M., Fafoutis, Eleni, Brown, Michael G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8308748/
https://www.ncbi.nlm.nih.gov/pubmed/34358058
http://dx.doi.org/10.3390/pathogens10070908
_version_ 1783728355565109248
author Cronk, John M.
Fafoutis, Eleni
Brown, Michael G.
author_facet Cronk, John M.
Fafoutis, Eleni
Brown, Michael G.
author_sort Cronk, John M.
collection PubMed
description Immunoreceptor tyrosine-based inhibitory motif (ITIM)-bearing receptors (IRs) enable discrimination between self- and non-self molecules on the surface of host target cells. In this regard, they have a vital role in self-tolerance through binding and activating intracellular tyrosine phosphatases which can inhibit cellular activation. Yet, self-MHC class I (MHC I)-specific IRs are versatile in that they can also positively impact lymphocyte functionality, as exemplified by their role in natural killer (NK) cell education, often referred to as ’licensing‘. Recent discoveries using defined mouse models of cytomegalovirus (CMV) infection have revealed that select self-MHC I IRs can increase NK cell antiviral defenses as well, whereas other licensing IRs cannot, or instead impede virus-specific NK responses for reasons that remain poorly understood. This review highlights a role for self-MHC I ‘licensing’ IRs in antiviral immunity, especially in the context of CMV infection, their impact on virus-specific NK cells during acute infection, and their potential to affect viral pathogenesis and disease.
format Online
Article
Text
id pubmed-8308748
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-83087482021-07-25 Licensing Natural Killers for Antiviral Immunity Cronk, John M. Fafoutis, Eleni Brown, Michael G. Pathogens Review Immunoreceptor tyrosine-based inhibitory motif (ITIM)-bearing receptors (IRs) enable discrimination between self- and non-self molecules on the surface of host target cells. In this regard, they have a vital role in self-tolerance through binding and activating intracellular tyrosine phosphatases which can inhibit cellular activation. Yet, self-MHC class I (MHC I)-specific IRs are versatile in that they can also positively impact lymphocyte functionality, as exemplified by their role in natural killer (NK) cell education, often referred to as ’licensing‘. Recent discoveries using defined mouse models of cytomegalovirus (CMV) infection have revealed that select self-MHC I IRs can increase NK cell antiviral defenses as well, whereas other licensing IRs cannot, or instead impede virus-specific NK responses for reasons that remain poorly understood. This review highlights a role for self-MHC I ‘licensing’ IRs in antiviral immunity, especially in the context of CMV infection, their impact on virus-specific NK cells during acute infection, and their potential to affect viral pathogenesis and disease. MDPI 2021-07-19 /pmc/articles/PMC8308748/ /pubmed/34358058 http://dx.doi.org/10.3390/pathogens10070908 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Cronk, John M.
Fafoutis, Eleni
Brown, Michael G.
Licensing Natural Killers for Antiviral Immunity
title Licensing Natural Killers for Antiviral Immunity
title_full Licensing Natural Killers for Antiviral Immunity
title_fullStr Licensing Natural Killers for Antiviral Immunity
title_full_unstemmed Licensing Natural Killers for Antiviral Immunity
title_short Licensing Natural Killers for Antiviral Immunity
title_sort licensing natural killers for antiviral immunity
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8308748/
https://www.ncbi.nlm.nih.gov/pubmed/34358058
http://dx.doi.org/10.3390/pathogens10070908
work_keys_str_mv AT cronkjohnm licensingnaturalkillersforantiviralimmunity
AT fafoutiseleni licensingnaturalkillersforantiviralimmunity
AT brownmichaelg licensingnaturalkillersforantiviralimmunity